Erudio Healtherudio.com
Sponsor
Exelixis trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Exelixis yet. Erudio has found public clinician commentary on 9 clinical trials sponsored by Exelixis, including CONTACT-02, COSMIC-312, STELLAR-002 and STELLAR-304. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Exelixis). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CONTACT-02 NCT04446117 · Exelixis DeepView → | metastatic castration-resistant prostate cancer | Phase 3 | Deep | View | |||
| STELLAR-304 NCT05678673 · Exelixis DeepView → | advanced or metastatic non-clear cell renal cell carcinoma | Phase 3 | Deep | View | |||
| STELLAR-002 NCT05176483 · Exelixis DeepView → | unresectable advanced or metastatic solid tumors | Phase 1 | Deep | View | |||
| COSMIC-312 NCT03755791 · Exelixis DeepView → | treatment-naive advanced hepatocellular carcinoma | Phase 3 | Deep | View | |||
| COSMIC-313 NCT03937219 · Exelixis StandardView → | previously untreated intermediate/poor-risk advanced renal cell carcinoma | Phase 3 | Standard | View | |||
| STELLAR-303 NCT05425940 · Exelixis FocusedView → | previously treated metastatic colorectal cancer | Phase 3 | Focused | View | |||
| STELLAR-311 NCT06943755 · Exelixis FocusedView → | previously treated locally advanced or metastatic neuroendocrine tumors | Phase 2/Phase 3 | Focused | View | |||
| EXAM NCT00704730 · Exelixis FocusedView → | unresectable, locally advanced or metastatic medullary thyroid cancer | Phase 3 | Focused | View | |||
| COSMIC-021 NCT03170960 · Exelixis FocusedView → | locally advanced or metastatic solid tumors | Phase 1 | Focused | View | |||